Optum Pharmacy 801, Inc., a 503A certified specialty pharmacy subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs for chemotherapy drug compounding services. The contract, valued at $124,987.94 with a period of performance through August 31, 2026, represents a firm fixed-price procurement with no set-aside designation. The awarded task order, issued September 1, 2025, is valued at $124,992.67 and specifies performance in Phoenix, Arizona, with services directed to support the New Jersey Health Care System Toms River, New Jersey Campus. This procurement fulfills the VA's requirement for specialized pharmaceutical compounding services that adhere to strict regulatory and operational standards.
The contract scope encompasses the preparation of hazardous chemotherapy medications in compliance with United States Pharmacopeia standards 797 and 800, utilizing aseptic technique protocols and closed-system transfer devices such as Equishield technology. Service delivery requirements include same-day fulfillment with prescriptions received by 11:30 AM requiring delivery by 8:00 AM the following treatment day, with proper hazardous material labeling and temperature-controlled shipping. The solicitation was published as a Special Notice on June 30, 2025, identifying Optum Pharmacy 801, Inc. as the intended sole-source contractor under Federal Acquisition Regulation 13.105(a) authority, reflecting the contractor's established capability to meet complex regulatory requirements and time-sensitive operational demands for VA oncology support programs. The procurement falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and Procurement Service Code 6505 (Drugs and Biologicals).